Status:
COMPLETED
Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Polyhydramnios
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
To compare the efficiency and maternal and fetal tolerance of two techniques of amnioreduction used in cases of symptomatic second and third trimester polyhydramnios: syringe manual aspiration techniq...
Detailed Description
Polyhydramnios is defined as more than 2 liters of amniotic fluid. Ultrasound diagnosis is made either by measurement of a deepest vertical pocket exceeding 8 cm, or by use of an amniotic fluid index ...
Eligibility Criteria
Inclusion
- Pregnant women with abdomen discumfort and ultrasound diagnosis of polyhydramnios (AFI\>25cm)
- Single or twin pregnancies
Exclusion
- Multiple pregnancy (more than 3 fetuses)
- Maternal history of placental abruptio
- Fetus with IUGR
- Pregnancy complicated with pre-eclampsia
- Unability to give informed consent
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2005
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00236340
Start Date
January 1 2002
End Date
February 1 2005
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bretonneau
Tours, Centre-Val de Loire, France, 37000